The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis

Author:

Conforti Franco12,Davies Elizabeth R.12,Calderwood Claire J.1,Thatcher Thomas H.3,Jones Mark G.12,Smart David E.12,Mahajan Sumeet4,Alzetani Aiman5,Havelock Tom25,Maher Toby M.67,Molyneaux Philip L.67,Thorley Andrew J.7,Tetley Teresa D.7,Warner Jane A.124,Packham Graham8,Ganesan A.9,Skipp Paul J.4,Marshall Benjamin J.5,Richeldi Luca125,Sime Patricia J.3,O’Reilly Katherine M.A.21011,Davies Donna E.124

Affiliation:

1. The Brooke Laboratory, Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK

2. NIHR Respiratory Biomedical Research Unit, University Hospital Southampton, Southampton, UK

3. Department of Medicine/Pulmonary & Critical Care, University of Rochester, Rochester, NY, USA

4. Institute for Life Sciences, University of Southampton, Highfield, UK

5. University Hospital Southampton, Southampton, UK

6. NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, UK

7. National Heart & Lung Institute, Faculty of Medicine, Imperial College, London, UK

8. Cancer Sciences, University of Southampton Faculty of Medicine, University Hospital Southampton, Southampton, UK

9. School of Pharmacy, University of East Anglia, Norwich, UK

10. Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland

11. School of Medicine and Medical Science, University College, Dublin, Ireland

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3